ASCENTAGE PHARMA GROUP INTERNATIONAL

Insiders Ascentage Pharma Group International

Equities

6855

KYG0519B1023

Market Closed - Hong Kong S.E. Other stock markets 09:08:20 14/05/2024 BST			5-day change	1st Jan Change
21 ^HKD	+0.48%		+8.70%	-23.08%

04-25	Ascentage Pharma to Present Four Studies at US Oncology Meet	MT
04-09	Ascentage Pharma Chairman Boosts Stake in Firm	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ascentage Pharma Chairman Boosts Stake in Firm	04-09	MT
Ascentage Pharma Group Directors Acquire Company Shares	04-04	MT
Ascentage Pharma Announces Board Changes	03/04/23	CI
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program	25/07/22	PR
Ascentage Pharma Group International Announces Management Changes, Effective May 20, 2022	19/05/22	CI
Ascentage Pharma Appoints Former Fosun Pharma Exec as New CFO	30/11/21	MT
Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer	29/11/21	CI
Ascentage Pharma CFO Resigns; Shares Fall 5%	02/11/21	MT
Ascentage Pharma Group International Announces Resignation of Su Zhang as Chief Financial Officer	01/11/21	CI
Guo Edward Ming to Retire as Chief Operating Officer of the Ascentage Pharma Group International, Effective October 31, 2021	30/08/21	CI
-Ascentage Pharma Appoints Renowned Oncologist Dr. David Sidransky, MD, to its Board as an Independent Non-Executive Director	13/04/21	CI
Ascentage Pharma Group International Announces Board Changes	31/03/21	CI
Ascentage Pharma Appoints Gang Zhu as Chief Commercial Officer to Lead Commercial Initiatives	04/12/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer